Event-free survival at 3 ( 12 ) months was observed in 80.6 % ( 72.3 % ) of patients randomized to a mid-septal and in 82.2 % ( 72.1 % ) of patients randomized to an apical lead position , p = 0.726 ( p = 0.969 ) .